While women tend to be most concerned with cancers such as breast, colorectal, and endometrial, thyroid cancer should be on ...

Pulse Biosciences, Inc. , developer of the novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced first patient ...

Study finds up to 94% of papillary thyroid cancers in the past three decades were overdiagnosed, with stable mortality rates, despite soaring detection rates.

After undergoing surgery to remove an overactive thyroid in 2014, games designer and publisher Xeo Lye had jokingly asked his doctor how long he could survive without thyroid hormone replacement pills ...

Pulse Biosciences (Nasdaq:PLSE) today announced clinical findings demonstrating the durability of its nPulse Vybrance system.

Pulse Biosciences, Inc. , developer of the novel nPulsetm technology using proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced clinical data on outcomes ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced clinical data ...

In an apparent blunder by his propaganda machine, the entire sequence was initially released, showing the coughing fit to ...

Gastrointestinal GI cancer explained An expert shares symptoms early warning signs of stomach cancer risk factors and treatment options for early detection ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of the novel nPulse™ technology using its proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced its nPulse ...

DeepHealth is introducing in Europe its cloud-first integrated portfolio combining clinical AI, multi-modality viewing and reporting, which is designed to improve outcomes, efficiency and access to ca ...